The Challenge of Wound Healing in Patients with Chronic Kidney Disease
Janice C. Colwell
Question: How is wound healing affected in the person with chronic kidney disease?
Answer:
The rise in the incidence and prevalence of patients with wounds can be
attributed to the increase in patients needing acute care, long-term
care, and home care, as well as those with uncontrolled diabetes and
nutritional impairment. Approximately 5 million individuals in the
United States have some type of chronic nonhealing wound often
associated with inadequate blood flow (Hall & Schumann, 2001).
While there are numerous wound care topical treatments, a thorough
understanding of wound healing will guide decision making. This article
will briefly review the wound healing process and the risk factors that
the patient with chronic kidney disease (CKD) may have that can affect
wound healing.
Wound
healing is a process that involves a series of complex events that
starts with the injury and ends with wound closure. To understand how
wound healing is affected in the person with kidney disease, the phases
of wound healing will be reviewed.
There
are two types of wounds: those with loss of tissue and those without.
Partial thickness wounds are shallow wounds involving loss of the
epidermis (top layer) and possible partial loss of the dermis. These
wounds heal by regeneration because the epidermis can regenerate. A
clean surgical incision or an abrasion is an example of a wound with
little tissue loss. The skin edges approximate and healing occurs
quickly; the wound is resurfaced between day 4 and 7 (Waldrop &
Doherty, 2000). In contrast, a wound involving loss of tissue heals by
secondary intention. These full thickness wounds extend through the
epidermis into the dermis and heal by scar tissue formation.
Partial Thickness Wound Repair
The phases of partial thickness wound repair include the
inflammatory response, epithelial proliferation and migration, and
re-establishment of the epidermal layers. The inflammatory response is
triggered by tissue trauma, causing redness and swelling to the area
with a moderate amount of serous exudate. This response is generally
limited to 24 hours post-wounding. Epithelial cells begin to migrate
across the wound bed soon after the wound occurs. The epithelial cells
begin to proliferate, providing new cells to replace the lost cells.
Epithelial proliferation and migration starts at both the wound edges
and the epidermal cells lining the epidermal appendages allowing for
quick resurfacing. New epithelium is only a few cells thick and must
undergo re-establishment of the epidermal layers. The cells slowly
re-establish normal thickness and appear as dry pink tissue.
Full Thickness Wound Repair
The three phases of full thickness repair include: inflammatory,
proliferative, and remodeling. The inflammatory phase begins within
minutes of the injury and lasts approximately 3 days. Hemostasis causes
blood vessels to constrict and platelets to gather to stop bleeding.
Clots form a fibrin matrix that will provide a framework for cellular
repair. Damaged tissue and mast cells secrete histamine, resulting in
vasodilatation of surrounding capillaries and exudation of serum and
white blood cells into damaged tissues. This results in localized
redness, edema, and warmth. Leukocytes reach the wound within a few
hours. The primary acting white blood cell is the neutrophil, which
begins to ingest bacteria and small debris. The second important
leukocyte is the monocyte, which transforms into macrophages. The
macrophages are the “garbage cells” that clean a wound of bacteria,
dead cells, and debris. Macrophages continue the process of clearing
the wound of debris and release growth factors that attract
fibroblasts, the cells that synthesize collagen (connective tissue).
Collagen can be found as early as the second day and is the main
component of scar tissue. In a clean wound, the inflammatory phase
accomplishes control of bleeding and the establishment of a clean wound
bed. The inflammatory phase is prolonged if too little inflammation
occurs, as in debilitating kidney disease or after administration of
steroids. Too much inflammation also prolongs healing because arriving
cells compete for available nutrients.
With
the appearance of new blood vessels, the proliferative phase begins and
lasts from 3 to 24 days. The main activities in this phase include the
filling of the wound with granulation tissue, contraction, and
re-surfacing of the wound by epithelialization. Fibroblasts are present
in this phase and are the cells that synthesize collagen, providing the
matrix for granulation. Collagen mixes with the granulation tissue, and
this matrix will support the re-epithelialization and provide strength
and structural integrity. During this period, the wound contracts to
reduce the area that requires healing. Lastly, the epithelial cells
migrate from the wound edges to resurface. In a clean wound, in
the proliferative phase, the vascular bed re-establishes (granulation
tissue), the area is filled with replacement tissue (collagen,
contraction, and granulation tissue), and the surface is repaired
(epithelialization). Impairment of healing during this stage usually
results from systemic factors such as age, anemia, hypoproteinemia, and
zinc deficiency.
Remodeling,
the final stage of healing, may take more than a year, depending on the
depth and extent of the wound. The collagen scar continues to
reorganize and gain strength for several months. However, a healed
wound usually does not have the tensile strength of the tissue it
replaces. Collagen fibers undergo remodeling or reorganization before
assuming their normal appearance. Usually scar tissue contains fewer
pigmented cells and has a lighter color than normal skin.
Wound Healing Risk Factors
Wound
healing is vulnerable to a number of factors that may be present in the
person with kidney disease. Diabetes mellitus is an important risk
factor for both development of wounds as well as infection and failed
healing. Elevated blood glucose levels are associated with significant
reduction in phagocytic ability of the white blood cells and diminished
wound strength (West & Gimbel, 2000). Wound repair in patients with
diabetes is characterized by reduced collagen synthesis and deposition,
decreased wound breaking strength, and impaired leukocyte function.
Insulin therapy and exogenous growth factors have been shown to
increase collagen deposition and improve tensile strength. Many of the
adverse effects of diabetes are at least partially related to glycemic
control, as well as measures to maximize tissue perfusion and reduce
repetitive trauma (Waldrop & Doughty, 2000). Careful monitoring and
control of blood glucose can facilitate wound healing.
Hypertension
produces changes to blood vessel walls, which can contribute to
peripheral arterial disease. Artherosclerotic disease can result in
chronic reduction in blood flow to tissues and, in some cases, the
development of ulcerations especially in the lower extremities. Wounds
in the limbs of persons with artherosclerotic disease can be difficult
to heal because of the poor perfusion.
An
acute or chronic illness such as kidney disease can compromise
cardiovascular function and precipitate hypoxia. Restricted tissue
perfusion will delay the phases of wound healing making the patient
with a wound susceptible to infection and other wound healing issues.
Renal failure and edema increase tissue nutritional needs or diminished
flow contributing to tissue hypoxia.
A
patient with CKD has a disrupted defense response as manifested by
depressed neutrophil function, leucopenia related to complement
activation, diminished T and B lymphocyte function, and a reduction in
natural killer cell activity (Headley & Wall, 2002). Thus, the
inflammatory response to wounding will be altered making the patient
with CKD more susceptible to infection.
Conclusion
Wound
healing in the person with kidney disease can be compromised if the
following risk factors are present: diabetes mellitus, hypertension,
and artherosclerotic disease as well as restricted perfusion. Each
renal patient with a wound should be evaluated for wound healing risk
factors, and, if possible, those risk factors should be reduced or
corrected. Decreasing or eliminating the risk factors will facilitate
each phase of wound healing, decrease the risk of infection, and
support the person with a wound to move onto healing.
References
Hall,
P., & Schumann, L. (2001). Wound care: Meeting the challenge.
Journal of the American Academy of Nurse Practitioners, 13, 258-266.
Headley,
C., & Wall, B. (2002), ESRD-Associated cutaneous manifestations in
a hemodialysis population. Nephrology Nursing Journal, 29, 525-539.
Waldrop,
J.,& Doughty, D. (2000). Wound healing physiology. In R.A. Byrant
(Ed.), Acute and chronic wounds: Nursing management (pp. 17-43). St.
Louis: Mosby.
West,
J.M., & Gimbel, M.L. (2000). Acute surgical and traumatic wound
healing. In R.A. Byrant (Ed.), Acute and chronic wounds: Nursing
management (pp. 197-203). St. Louis: Mosby.
| The
Clinical Consult department is designed to provide answers to questions
concerning clinical problems and to report innovative clinical
practices. Readers are invited to submit questions to be answered by a
guest consultant. Questions should provide background information and
state specific information requested. Answers will be referenced.
Manuscripts that address clinical problems or present innovative ideas
are also invited. These should be between 400 and 600 words and contain
one to three references. Address correspondence to: Charlotte Szromba,
Clinical Consult Department Editor, through the ANNA National Office;
East Holly Avenue/Box 56; Pitman NJ 08071-0056; (856) 256-2320. You may
also log onto this column at www.nephrologynursingjournal.net (click on
Department link) and email your comments to the Department Editor (see
Discussion Area). The opinions and assertions contained herein are the
private views of the contributors and do not necessarily reflect the
views of the American Nephrology Nurses’ Association. |
|